The most frequent complications included erosion through vaginal epithelium, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence.
Past News ReleasesRSS
(PRWEB) September 21, 2011
Flood Law Group, LLP, a litigation firm, is sponsoring TransvaginalMeshLawsuits.com, an online resource that aims to provide useful information about the injuries that have been associated with surgical mesh to treat pelvic organ prolapse (POP).
According to Flood Law Group, LLP, women who experience complications after being treated with transvaginal mesh might qualify for financial compensation.
The U.S. Food and Drug Administration (FDA) issued a safety alert on July 13, 2011 to notify health care providers and consumers about the possible complications of transvaginal mesh when used to treat POP and stress urinary incontinence (SUI). According to the alert, the FDA received more than 1,000 reports of complications with the devices in the last three years.
“The most frequent complications included erosion through vaginal epithelium, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence,” the FDA said in the alert. “There were also reports of bowel, bladder, and blood vessel perforation during insertion. In some cases, vaginal scarring and mesh erosion led to a significant decrease in patient quality of life due to discomfort and pain, including dyspareunia.”
The FDA recommends in the alert that physicians obtain specialized training, watch for complications and inform patients of the potential risks.
Pelvic organ prolapse is a condition that affects thousands of women after childbirth. Stress from pregnancy, labor and delivery can weaken the muscles and tissue surrounding the uterus, bladder, bowel and top of the vagina, causing the organs to sag or prolapse into the vagina.
POP has been treated via surgery for many years. The FDA approved use of surgical mesh to reinforce the tissue following surgery in 2002.
TransvaginalMeshLawsuits.com is an online resource that aims to provide women who have POP with information about the possible risk of injuries, infection and pain.
For more information, please call 1-888-255-1253.